Medicated Skin Care Products - Global Market Trajectory & Analytics

Global Medicated Skin Care Products Market to Reach $8.1 Billion by 2027

Amid the COVID-19 crisis, the global market for Medicated Skin Care Products estimated at US$7 Billion in the year 2020, is projected to reach a revised size of US$8.1 Billion by 2027, growing at a CAGR of 2.1% over the period 2020-2027.

The U.S. Market is Estimated at $1.9 Billion, While China is Forecast to Grow at 4.1% CAGR

The Medicated Skin Care Products market in the U.S. is estimated at US$1.9 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$1.6 Billion by the year 2027 trailing a CAGR of 4.1% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 0.4% and 1.5% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 0.9% CAGR.

Select Competitors (Total 120 Featured):

• Advanced Dermatology Corp.
• Bayer AG
• Beiersdorf AG
• Chattem Inc.
• EltaMD Inc.
• Episciences Inc.
• Galderma S.A.
• GlaxoSmithKline Plc
• IntraDerm™ Pharmaceuticals
• Johnson & Johnson
• Kao Corporation
• La Prairie Group AG
• Laboratorios Leti SL
• L`Oréal S.A.
• Medimetriks Pharmaceuticals Inc.
• Merz Pharma GmbH & Co. KGaA
• NEOCUTIS
• Obagi Medical Products Inc.
• Otsuka Pharmaceutical Co. Ltd.
• PCA Skin
• Pfizer Inc.
• Shiseido Co. Ltd.
• SkinCeuticals
• SkinMedica Inc.
• Skinvisible Pharmaceuticals Inc.
• Stiefel Laboratories Inc.
• Taisho Pharmaceuticals Co. Ltd.
• The Himalaya Drug Company
• Unilever NV
• Valeant Pharmaceuticals International Inc.
• Vivier Pharma
• ZO® Skin Health Inc.